ClinicalTrials.Veeva

Menu

Endurance and Walking Training by Nordic Walking in Multiple Sclerosis

M

Multiple Sclerosis Center of Catalonia

Status

Completed

Conditions

Multiple Sclerosis

Treatments

Behavioral: Conventional endurance training
Behavioral: Nordic Walking Training

Study type

Interventional

Funder types

Other

Identifiers

NCT03976128
Nordic Walking in MS

Details and patient eligibility

About

Walking capacity is one of the most valuable body functions among persons with multiple sclerosis (MS) and it is one of the most frequently affected, even in early stages of the disease. Inactivity and deconditioning can accelerate gait impairment and promote other pathologies related with sedentary lifestyle.

Nordic walking (NW) is a fun and effective fitness and rehabilitation activity. The benefits of NW have been extensively described in healthy and elderly population (Tschentscher, 2013; Kappor, 2013) and it is proving to be highly recommended to different neurological conditions, specially to Parkinson Disease (Reuter 2006; van Eijkeren 2008; Fritz 2011; Ebersbach 2014).

There is no evidence on NW and MS, although it's supposed to be an ideal physical activity for many reasons: it tones the upper and lower body at the same time, uses 90% of the skeletal muscles, burns up to 46% more calories than ordinary walking, reduces the pressure on knees and joints, poles propel the walker along easier and faster and it is one of the most effective cross training techniques for people who require improve cardiovascular and endurance conditioning.

Full description

A simple blinded randomized controlled trial as designed to assess if an endurance training (20 sessions of 45 minutes x 2 times/week x 10 weeks) using NW improves: walking capacity, balance, fatigue, mood and health-related quality of life of people with MS.

66 people with MS will be randomly allocated in NW group or conventional endurance training group (treadmill and cycloergometer). Assessments will take place before starting the training, after the training and 3 months after.

Enrollment

66 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • People over 18 diagnosed of MS following the Mc Donald criteria, clinically stable who:
  • show mild to moderate balance disorder (BBS>45). Mild risk of falls.
  • refer fatigue during walking and restriction on their usual walking distance during the last 6 months.
  • Accept to participate in the study and signed the informed consent.

Exclusion criteria

  • Other neurological disorders.
  • Moderate to severe spasticity (Ashworth>2)
  • Non stable heart diseases, diabetes mellitus, arthritis in lower limbs, acute pain in lower limbs, peripheral neuropathies, severe orthopedics problems, psychiatric problems, pregnancy.
  • Incapacity to maintain a minimum walking rhythm at least during 15 minutes.
  • Cognitive disability or body schema disorder that limits to fill in the assessment questionaires or understanding and applying the technique.
  • To be training in other physical activities that can modify the level of fatigue or walking ability.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

66 participants in 2 patient groups

Nordic Walking training
Experimental group
Description:
20 sessions of 45 minutes x 2 times/week x 10 weeks using NW
Treatment:
Behavioral: Nordic Walking Training
Conventional endurance training
Active Comparator group
Description:
20 sessions of 45 minutes x 2 times/week x 10 weeks using treadmill and cycloergometer training.
Treatment:
Behavioral: Conventional endurance training

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems